185P Long-term efficacy of trastuzumab biosimilar CT-P6 in patients with HER2-positive early breast cancer: 6-year survival analysis of phase III study results
Title:
185P Long-term efficacy of trastuzumab biosimilar CT-P6 in patients with HER2-positive early breast cancer: 6-year survival analysis of phase III study results
Author:
Stebbing, J. Baranau, Y. Baryash, V. Moiseyenko, V. Boliukh, D. Antone, N.Z. Manikhas, A. Chornobai, A. Kim, S.H. Ahn, K. Park, T. Baek, E.H. Park, S. Lee, S.J. Chang, I.S. Kim, S.H. Lee, J.Y. Choi, J.I.